TKD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 27.1 EUR -0.77%

Market Cap: €42.5B

T	Takeda Pharmaceutical Co Ltd DUS:TKD	JP
	Suncor Energy Inc TSX:SU	CA
S	Standard Chartered PLC SWB:STD	UK
	Delta Air Lines Inc NYSE:DAL	US
	Parker-Hannifin Corp NYSE:PH	US
	Dominion Energy Inc NYSE:D	US
	Pierre et Vacances SA PAR:VAC	FR
R	Relx PLC SWB:RDEB	UK
C	CITIC Securities Co Ltd XMUN:CI9	CN
	Novartis AG F:NOT	CH
H	HALEON PLC F:H6D	UK
M	Marsh & McLennan Companies Inc XMUN:MSN	US
I	ITV PLC OTC:ITVPY	UK
U	United Parcel Service Inc DUS:UPAB	US
R	Radian Group Inc XMUN:RAG	US
	Centrale del Latte d'Italia SpA MIL:CLI	IT
R	Resonac Holdings Corp XMUN:SWD	JP

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

11%

Declining Operating Margin

14% > 11%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

8% > 3%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.